[Federal Register Volume 79, Number 81 (Monday, April 28, 2014)]
[Notices]
[Pages 23374-23375]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2014-09578]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Importer of Controlled Substances; Notice of Registration; S & B 
Pharma, Inc.

    By Notice dated January 15, 2014, and published in the Federal 
Register on February 4, 2014, 79 FR 6630, S & B Pharma, Inc., DBA Norac 
Pharma, 405 S. Motor Avenue, Azusa, California 91702-3232, made 
application to the Drug Enforcement Administration (DEA) to be 
registered as an importer of the following basic classes of controlled 
substances:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
4-Anilino-N-phenethyl-4-piperidine (8333)..  II
Tapentadol (9780)..........................  II
------------------------------------------------------------------------

    The company plans to import the listed controlled substances for 
internal use, and to manufacture bulk intermediates for sale to its 
customers.
    On February 10, 2014, S & B Pharma, Inc., withdrew its request for 
the addition of Fentanyl (9801) to this registration.
    No comments or objections have been received. The DEA has 
considered the factors in 21 U.S.C. 823(a) and 952(a), and determined 
that the registration of S & B Pharma, Inc. to import the basic classes 
of controlled substances is consistent with the public interest and in 
accordance with United States obligations under international treaties, 
conventions, or protocols in effect on May 1, 1971. The DEA has 
investigated S & B Pharma, Inc. to ensure that the company's 
registration is consistent with the public interest. The investigation 
has included inspection and testing of the company's physical security 
systems, verification of the company's compliance with state and local 
laws, and a review of the company's background and history.

[[Page 23375]]

    Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in 
accordance with 21 CFR 1301.34, the above named company is granted 
registration as an importer of the basic classes of controlled 
substances listed.

    Dated: April 21, 2014.
 Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 2014-09578 Filed 4-25-14; 8:45 am]
BILLING CODE 4410-09-P